Pharmaceutical

Eli Lilly’s Zepbound to be issued in single-dose vials for self-payers

Eli Lilly has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults with obesity.

Aug 29, 2024 - 04:00
Eli Lilly’s Zepbound to be issued in single-dose vials for self-payers
Eli Lilly has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults with obesity.
Read the original article

Tags:

Previous Article

Pfizer launches digital healthcare platform to streamline access

Next Article

EC upgrades approval for J&J’s Rybrevant/chemotherapy combination in NSCLC

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Contact sports cause CTE. So why are Americans watching more football than ever?

Opinion: Contact sports cause CTE. So why are Americans...

Feb 9, 2024

STAT+: Powerful Senate duo drops a bipartisan PBM reform plan

STAT+: Powerful Senate duo drops a bipartisan PBM refor...

Apr 21, 2023

The White House has a pharmacy — and it was a mess, a new investigation found

The White House has a pharmacy — and it was a mess, a n...

Jan 24, 2024